ECOSLOPS (ALESA.PA) Fundamental Analysis & Valuation

EPA:ALESA • FR0011490648

Current stock price

1.16 EUR
+0.01 (+0.87%)
Last:

This ALESA.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALESA.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALESA has reported negative net income.
  • ALESA had a positive operating cash flow in the past year.
  • In the past 5 years ALESA always reported negative net income.
  • ALESA had negative operating cash flow in 4 of the past 5 years.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M -10M

1.2 Ratios

  • The Return On Assets of ALESA (-12.91%) is worse than 77.78% of its industry peers.
  • Looking at the Return On Equity, with a value of -76.91%, ALESA is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
ROA -12.91%
ROE -76.91%
ROIC N/A
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • Looking at the Gross Margin, with a value of 64.42%, ALESA is in the better half of the industry, outperforming 71.11% of the companies in the same industry.
  • ALESA's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALESA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALESA.PA Health Analysis

2.1 Basic Checks

  • ALESA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALESA has about the same amount of shares outstanding.
  • ALESA has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALESA has a worse debt to assets ratio.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • ALESA has an Altman-Z score of -1.59. This is a bad value and indicates that ALESA is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.59, ALESA is not doing good in the industry: 84.44% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of ALESA is 48.08, which is on the high side as it means it would take ALESA, 48.08 years of fcf income to pay off all of its debts.
  • ALESA has a worse Debt to FCF ratio (48.08) than 60.00% of its industry peers.
  • ALESA has a Debt/Equity ratio of 3.78. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 3.78, ALESA is not doing good in the industry: 82.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF 48.08
Altman-Z -1.59
ROIC/WACCN/A
WACC10.07%
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 2.76 indicates that ALESA has no problem at all paying its short term obligations.
  • ALESA has a better Current ratio (2.76) than 93.33% of its industry peers.
  • ALESA has a Quick Ratio of 2.48. This indicates that ALESA is financially healthy and has no problem in meeting its short term obligations.
  • ALESA's Quick ratio of 2.48 is amongst the best of the industry. ALESA outperforms 91.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.48
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALESA.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.51% over the past year.
  • ALESA shows a small growth in Revenue. In the last year, the Revenue has grown by 4.19%.
  • ALESA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.43% yearly.
EPS 1Y (TTM)5.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.8%
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALESA.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALESA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 2.28, which indicates a rather cheap valuation of ALESA.
  • ALESA's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALESA is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ALESA to the average of the S&P500 Index (38.20), we can say ALESA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.28
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • ALESA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 17.6
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALESA.PA Dividend Analysis

5.1 Amount

  • No dividends for ALESA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALESA.PA Fundamentals: All Metrics, Ratios and Statistics

ECOSLOPS

EPA:ALESA (4/15/2026, 7:00:00 PM)

1.16

+0.01 (+0.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-08
Earnings (Next)07-16
Inst Owners10.61%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.02M
Revenue(TTM)11.36M
Net Income(TTM)-3.07M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.28
P/S 0.53
P/FCF 17.6
P/OCF 5
P/B 1.51
P/tB 2.09
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)0.51
Fwd EY43.95%
FCF(TTM)0.07
FCFY5.68%
OCF(TTM)0.23
OCFY19.98%
SpS2.19
BVpS0.77
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -12.91%
ROE -76.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.42%
FCFM 3.01%
ROA(3y)-12.21%
ROA(5y)-10.84%
ROE(3y)-51.34%
ROE(5y)-41.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.62%
GM growth 5Y14.46%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF 48.08
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.76
Quick Ratio 2.48
Altman-Z -1.59
F-Score4
WACC10.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)5.97%
Cap/Sales(5y)39.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.8%
EPS Next Y211.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.19%
Revenue growth 3Y-2.59%
Revenue growth 5Y5.43%
Sales Q2Q%-2.41%
Revenue Next Year57.84%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-198.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1271.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y197.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y155.96%
OCF growth 3YN/A
OCF growth 5YN/A

ECOSLOPS / ALESA.PA Fundamental Analysis FAQ

What is the fundamental rating for ALESA stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALESA.PA.


What is the valuation status for ALESA stock?

ChartMill assigns a valuation rating of 4 / 10 to ECOSLOPS (ALESA.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for ECOSLOPS?

ECOSLOPS (ALESA.PA) has a profitability rating of 1 / 10.


How financially healthy is ECOSLOPS?

The financial health rating of ECOSLOPS (ALESA.PA) is 3 / 10.